Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data.
暂无分享,去创建一个
K. Wilner | D. Camidge | J. Cappelleri | G. Tremblay | T. Usari | P. Daniele | R. Wiltshire | L. Iadeluca | Michael Groff | Lauren Bartolome